EX-99.1 CHARTER 5 edgarfilings2004q3incstmt.htm
                                                                                                                                                              EXHIBIT 99.1
INGERSOLL-RAND COMPANY
Consolidated Income Statement
Third Quarter and Nine Months
(In millions, except percentages)
UNAUDITED
Three Months Nine Months
Ended September 30,
Ended September 30,
2004
2003
2004
2003
Revenues  $   2,368.0   $   2,064.0   $   6,934.6   $   6,002.3 
Cost of goods sold      1,738.8       1,523.7       5,076.3       4,474.7 
Selling & administrative expenses         351.0          329.4       1,035.9          968.4 
Restructuring charges              -               (1.9)              -               (1.9)




Operating income         278.2          212.8          822.4          561.1 
Interest expense          (35.7)          (42.1)        (116.1)        (135.7)
Other income (expense)             5.1             (3.9)             0.2             (4.8)




Earnings before taxes         247.6          166.8          706.5          420.6 
Provision for taxes           42.0            21.6            99.0            50.4 




Earnings from continuing operations         205.6          145.2          607.5          370.2 
Discontinued operations, net of tax           32.2              9.4            96.0            76.9 




Net earnings  $     237.8 
   $     154.6 
 $     703.5 
   $     447.1 
Basic earnings per share
Continuing operations  $       1.19   $       0.85   $       3.50   $       2.18 
Discontinued operations        0.18          0.05          0.55          0.45 
   
 
 
 
 $       1.37  $       0.90   $       4.05   $       2.63 




Diluted earnings per share
Continuing operations  $       1.18   $       0.83   $       3.46   $       2.15 
Discontinued operations         0.18          0.05          0.54          0.45 
   
 
 
 
 $       1.36   $       0.88   $       4.00   $       2.60 




Weighted-average number of common
shares outstanding:
   Basic         173.1          171.6          173.6          170.3 
   Diluted         175.0          174.8          175.7          171.8 
                 
SEE ATTACHED RELEASE FOR ADDITIONAL INFORMATION